Celularity Inc. Warrant (CELUW)

• Market cap: $858K
• 1 day: -22.00%
• 5 days: 4.00%
• 1 month: 7.73%
• 3 months: -35.11%
• 6 months: 74.11%
• Year to date: 95.00%
• 1 year: 25.00%
• 5 years: -94.26%
• 10 years: -93.50%
• Sector: Healthcare
• Industry: Biotechnology

About: Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Employees: 123

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

100% more capital invested

Capital invested by funds: $47.8K [Q4 2024] → $95.8K (+$48K) [Q1 2025]

0% more funds holding

Funds holding: 12 [Q4 2024] → 12 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.54% less ownership

Funds ownership: 11.58% [Q4 2024] → 11.04% (-0.54%) [Q1 2025]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3